group of patients with and without NPS were 5.44±2.03, 3.45±1.82; respectively (P<0.001). Pain was most frequently seen in wrist-hand (50.6%) and ankle-foot (43.4%) regions; albeit, NPS rates were highest in face (94.4%), lower leg (87.5%) and gluteal (78.6%) regions. SF 36 scores were lower in patients with NPS than the patients without NPS but the difference has not reached to a statistically significant level (P>0.05). The most associated factors with NPS were Medsger Disease Severity Score for muscle and drug consumption of the patient. Conclusions: According to our results, high frequency of NPS is seen in SSc patients, and NPS is associated with low QoL. The highest rates of NPS presence were seen in face, gluteal and lower leg regions of the body. The oral and pharyngeal esophageal phases were performed in the upright position, while the esophageal phase was performed in the proneoblique position, after administration of contrast material either in bolus form or diluted. Data were analyzed by radiologist with experience in videofluoroscopy for the evaluation of 17 videofluoroscopy items, of which, 4 concerning the oral, 4 the pharyngeal and 9 the esophageal phase, respectively. Results were expressed in a binary system. Then the main relevant videofluoroscopy findings were correlated with the principal scleroderma pattern of disease: lSSc vs dSSc; disease duration (more than 2 years) and subset of autoantibodies.
Conclusions: Our study demonstrated relevant abnormalities in swallowing functions in high number of patients with SSc. Pharyngeal and esophageal phases are the most affected, also early. Swallowing disorders increase with disease progression and involve similarly the limited or the diffuse SSc. An early and detailed diagnosis, supported by a semi-quantitative analysis with the use of videofluoroscopy scores, may be useful to guide the appropriate therapeutic approach, either rehabilitative or pharmacological, and finally, to improve the patient's quality of life. Extensive studies are necessary to confirm and transfer our data into clinical practice. Background: Systemic sclerosis (SSc) is characterized by fibrosis of the skin and visceral organs, especially digestive tract, and musculoskeletal involvement, which limit mobility/self-sufficiency of patients, and can have a negative impact on body composition. Objectives: To assess body composition and physical activity of SSc patients and healthy controls (HC). Methods: 59 patients with SSc (50 females, 9 males; mean age 52.1; disease duration 6.7 years; limited cutaneous (lcSSc,36)/diffuse cutaneous (dcSSc,23)) and 36 age-/sex-matched HC (30 females, 6 males, mean age 51.4) without rheumatic/tumor diseases or manifest cardiovascular event were included. SSc patients fulfilled EULAR/ACR 2013 criteria. Anthropometric parameters and body composition were assessed (by densitometry-iDXA Lunar, and by bioelectric impedance-BIA-2000-M), and physical activity was evaluated using Human Activity Profile (HAP) questionnaire. Routine biochemistry analysis was performed after 8 hours of fasting. Disease activity was evaluated by EUSTAR SSc activity score. Data are presented as mean±SD. Results: Compared to HC, patients with SSc had significantly lower body-mass index (BMI: 26.4±3.3 vs. 22.4±4.3 kg/m 2 , p<0.0001) and body fat % assessed by both iDXA (BF%: 37.2±6.6 vs. 32.6±8.2%, p=0.0014) and BIA (BF%: 31.1±6.4 vs.
